Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Five peptides containing amino acid sequences from the type 1 poliovirus structural protein VP1 have been synthesized. Each of the peptides was found capable of priming the immune system of rabbits for a long-lasting, virus-neutralizing IgG antibody response following a single inoculation of intact virus. One peptide directly induced the production of neutralizing antibody.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the complete neutralization of EMCV-3 capsids with EMCV-1 antisera suggests it is not a novel serotype but rather is a divergent EMCV-1 variant.”
From Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak (2026) · cites this paper as [80]
Citations
Cites
Prediction of protein antigenic determinants from amino acid sequences.
Hopp, T. P., & Woods, K. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3824 · Cited by 3,705
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose
Ey, P. L., Prowse, S. J., & Jenkin, C. R. (1978) · Immunochemistry · doi:10.1016/0161-5890(78)90070-6 · Cited by 2,685
Methods of Hormone Radioimmunoassay
(1978) · Elsevier eBooks · doi:10.1016/b978-0-123-79260-0.x5001-8 · Cited by 2,077
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction
Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,065
Primary structure, gene organization and polypeptide expression of poliovirus RNA
Kitamura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R., Lee, J. J., van der Werf, S., et al. (1981) · Nature · doi:10.1038/291547a0 · Cited by 914
Self-citationBittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., Lerner, R. A., Rowlands, D. J., & Brown, F. (1982) · Nature · doi:10.1038/298030a0 · Cited by 820
Racaniello, V. R., & Baltimore, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4887 · Cited by 550
Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine
Kleid, D. G., Yansura, D., Small, B., Dowbenko, D., Moore, D. M., Grubman, M. J., McKercher, P. D., Morgan, D. O., Robertson, B. H., & Bachrach, H. L. (1981) · Science · doi:10.1126/science.6272395 · Cited by 498
Liu, F.-T., Zinnecker, M., Hamaoka, T., & Katz, D. H. (1979) · Biochemistry · doi:10.1021/bi00571a022 · Cited by 460
Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.
Pfaff, E., Mussgay, M., Böhm, H. O., Schulz, G. E., & Schaller, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01262.x · Cited by 361
Research works printed but not linked: 7
- Icenogle, J., Shiwen, H., Duke, G., Rueckert, R. & Anderegg, J. Virology (in the press).
- Dernick, R. Devl biol. Stand. 47, 319–333 (1981).
- Blondel, B., Crainic, R. & Horodniceanu, F. C. r. hebd. Séanc. Acad. Sci., Paris 294, 91–94 (1982).
- Laporte, J., Grosclaude, J., Vantychem, J., Bernard, S. & Rouze, P. C. r. hebd. Séanc. Acad. Sci., Paris 276, 3399–3401 (1973).
- Van der Werf, S. et al. Proc. natn. acad. Sci. U.S.A. (in the press).
- Wimmer, E., Emini, E. A. & Jameson, B. A. Rev. infect. Dis. (in the press).
- Barany, G. & Merrifield, R. B. in The Peptides (eds Gross, E. & Meienhoffer, J.) 1–284 (Academic, New York, 1979).
Cited by
Items 101–200 of 235
Wetz, K., Willingmann, P., Zeichhardt, H., & Habermehl, K. ‐. (1986) · Archives of Virology · doi:10.1007/bf01314281 · Cited by 29
New poliovirus vaccines: a molecular approach☆
Almond, J. W., Stanway, G., Cann, A. J., Westrop, G. D., EVANS, D., Ferguson, M. A. J., MINOR, P., Spitz, M., & Schild, G. C. (1984) · Vaccine · doi:10.1016/0264-410x(84)90081-1 · Cited by 29
Production of Monoclonal and Monospecific Antibodies against Non-capsid Proteins of Poliovirus
Pasamontes, L., Egger, D., & Bienz, K. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-11-2415 · Cited by 28
“Polyclonal Abs against NCVPs have been induced by synthetic peptides (Baron & Baltimore, 1982; Emini et al., 1983) or by purified proteins (Hanecak et al., 1982; Semler et al., 1982, 1983).”
BackgroundVirion orientation in cubic crystals of the human common cold virus HRV14
Arnold, E., Erickson, J. W., Fout, G. S., Frankenberger, E. A., Hecht, H., Luo, M., Rossmann, M. G., & Rueckert, R. R. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90293-6 · Cited by 30
Molecular cloning and partial characterization of the coxsackievirus B3 genome
Tracy, S., Chapman, N. M., & Liu, H. L. (1985) · Archives of Virology · doi:10.1007/bf01317016 · Cited by 28
Francis, M. J., & Clarke, B. E. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(89)78044-7 · Cited by 28
Production of Poliovirus Vaccines: Past, Present, and Future
DUCHENE, M., Peetermans, J., D'Hondt, E., Harford, N., FABRY, L., & Stéphenne, J. (1990) · Viral Immunology · doi:10.1089/vim.1990.3.243 · Cited by 28
“Small synthetic peptides from VPI protein as well as purified VPI material containing sequential epitopes expressed in E. coll have to date failed to elicit neutralizing antibodies (96).”
Pütz, M. M., Hoebeke, J., Ammerlaan, W., Schneider, S., & Muller, C. P. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03517.x · Cited by 26
Jameson, B. A., Bonin, J., Wimmer, E., & Kew, O. M. (1985) · Virology · doi:10.1016/0042-6822(85)90121-7 · Cited by 26
Self-citationRossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., Hecht, H., Johnson, J. E., Kamer, G., Luo, M., Mosser, A. G., et al. (1987) · Springer eBooks · doi:10.1007/978-1-4684-5272-3_23 · Cited by 25
A Cassette Vector for the Construction of Antigen Chimaeras of Poliovirus
Burke, K. L., Evans, D. J., Jenkins, O. F., Meredith, J. M., D'Souza, E. D. A., & Almond, J. W. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-9-2475 · Cited by 25
Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy
Lin, J., Cheng, N., Hogle, J. M., Steven, A. C., & Belnap, D. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202014 · Cited by 24
Applications of Synthetic Peptides
Moser, R., Klauser, S., Leist, T. P., Langen, H., Epprecht, T., & Gutte, B. (1985) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198507193 · Cited by 25
Davis, D. A., Morein, B., Åkerblom, L., Lövgren‐Bengtsson, K., van Gils, M. E., Bogers, W. M. J. M., Teeuwsen, V. J. P., & Heeney, J. L. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00084-4 · Cited by 23
Recent developments in the field of biologically active peptides
Schmidt, G. (1986) · Topics in current chemistry · doi:10.1007/3-540-16724-2_8 · Cited by 23
Melnick, J. L. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0705-1_9 · Cited by 28
Poliovirus antigenic sites and vaccines
Wimmer, E., Jameson, B. A., & Emini, E. A. (1984) · Nature · doi:10.1038/308019a0 · Cited by 22
Self-citationHerremans, M. M. P. T., Reimerink, J. H. J., Ras, A., van der Avoort, H. G. A. M., Kimman, T. G., van Loon, A. M., Spaendonck, C.-V., & Koopmans, M. (1997) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.4.6.659-664.1997 · Cited by 22
“In animals, site 1 of serotype 3 is extremely immunodominant [ 3 ,9].”
BackgroundConstruction and characterization of a poliovirus/rhinovirus antigenic hybrid
Altmeyer, R. M., Murdin, A. D., Harber, J. J., & Wimmer, E. (1991) · Virology · doi:10.1016/0042-6822(91)90433-c · Cited by 22
Self-citationAntoni, G., Mariani, M., Presentini, R., Lafata, M., Neri, P., Bracci, L., & Cianfriglia, M. (1985) · Molecular Immunology · doi:10.1016/0161-5890(85)90042-2 · Cited by 20
Kennedy, R. C., Sparrow, J. T., Sanchez, Y., Melnick, J. L., & Dreesman, G. R. (1984) · Virology · doi:10.1016/0042-6822(84)90264-2 · Cited by 20
Rapid Monoclonal Antibody Generation Via Dendritic Cell Targeting In Vivo
Berry, J. D., Licea, A. F., Popkov, M., Cortez, X., Fuller, R. P., Elia, M., Kerwin, L., Kubitz, D. S., & Barbas, C. F. (2003) · Hybridoma and Hybridomics · doi:10.1089/153685903321538053 · Cited by 19
“(16,17) In these cases the protective peptides were identified by epitope mapping with neutralizing serum or MAbs.”
Carayanniotis, G., Vizi, E., Parker, J. M. R., Hodges, R. S., & Barber, B. H. (1988) · Molecular Immunology · doi:10.1016/0161-5890(88)90128-9 · Cited by 19
Controlled peptide‐protein conjugation by means of 3‐nitro‐2‐pyridinesulfenyl protection‐activation
Drijfhout, J. W., PERDIJK, E. W., Weijer, W. J., & Bloemhoff, W. (1988) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1988.tb00930.x · Cited by 18
Francis, M. J., Fry, C., Rowlands, D. J., & Brown, F. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-10-2483 · Cited by 18
Chin, L., Hinkula, J., Levi, M., Ohlin, M., Wahrén, B., & Borrebaeck, C. A. K. (1994) · PubMed Central · Cited by 18
New aspects of vaccine development.
Liew, F. Y. (1985) · PubMed Central · Cited by 18
van der Werf, S., Charbit, A., Leclerc, C., Mimic, V., Ronco, J., Girard, M. P., & Hofnung, M. J. (1990) · Vaccine · doi:10.1016/0264-410x(90)90057-s · Cited by 18
Charbit, A., van der Werf, S., Mimic, V., Boulain, J., Girard, M. P., & Hofnung, M. J. (1988) · Research in Microbiology · doi:10.1016/0769-2609(88)90096-8 · Cited by 18
Cui, X., Nagesha, H. S., & Holmes, I. H. (2003) · Journal of Virological Methods · doi:10.1016/s0166-0934(03)00049-1 · Cited by 17
Chemically Synthesized Peptides Elicit Neutralizing Antibody to Bovine Enterovirus
Smyth, M., Hoey, E. M., Trudgett, A., Martin, S. J., & Brown, F. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-1-231 · Cited by 18
Oral immunization with a synthetic peptide of cholera toxin B subunit
Gruaz‐Guyon, A., Delmas, A. F., Pedoussaut, S., Halimi, H., MILHAUD, G., Raulais, D., & Rivaille, P. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09918.x · Cited by 17
Synthetic peptides as vaccines
Regenmortel, M. H. V. V. (1999) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(08)70453-4 · Cited by 16
Wiegers, K. J., Wetz, K., & Dernick, R. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1283-1289.1990 · Cited by 16
“In some cases, synthetic peptides selected on the basis of hydrophilicity profiles of viral polypeptides were also found to induce a low neutralizing response (5, 9-11, 43).”
BackgroundThe Impact of New Technologies on Vaccine Development
Winther, M. D., & Dougan, G. (1984) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.1984.10647793 · Cited by 16
Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides
Auvinen, P., Mäkelä, M. J., Roivainen, M., Kallajoki, M. A., Vainionpää, R., & Hyypiä, T. (1993) · Apmis · doi:10.1111/j.1699-0463.1993.tb00141.x · Cited by 15
Pither, R. J., Zhang, C. X., Shiels, C., Tarlton, J. F., Finerty, S., & Morgan, A. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.1246-1251.1992 · Cited by 15
“Synthetic peptides have been shown to be capable of inducing protective immunity in a number of systems, including foot-andmouth disease virus (4), poliovirus (11, 14), herpes simplex virus (7), and hepatitis B virus (33).”
BackgroundRossmann, M. G., Arnold, E., Griffith, J. P., Kamer, G., Luo, M., Smith, T. J., Vriend, G., Rueckert, R. R., Sherry, B., McKinlay, M. A., et al. (1987) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(87)90149-6 · Cited by 19
Bright, R. K., Shearer, M. H., & Kennedy, R. C. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90103-1 · Cited by 15
Priming immune response to cholera toxin induced by synthetic peptides
Jacob, C. O., Grossfeld, S., Sela, M., & Arnon, R. (1986) · European Journal of Immunology · doi:10.1002/eji.1830160905 · Cited by 15
Priming for rotavirus neutralizing antibodies by a VP4 protein-derived synthetic peptide
Arias, C. F., Garcia, G., & López, S. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5393-5398.1989 · Cited by 14
Mapping Neutralization Domains of Viruses
Wimmer, E., Emini, E. A., & Diamond, D. C. (1986) · Springer eBooks · doi:10.1007/978-1-4612-4958-0_19 · Cited by 14
Self-citationKerr, P. J., Fitzgerald, S., Tregear, G. W., Dalgarno, L., & Weir, R. C. (1992) · Virology · doi:10.1016/0042-6822(92)90324-i · Cited by 13
Regions of poliovirus protein VP1 produced in Escherichia coli induce neutralizing antibodies
Hoatlin, M. E., Kew, O. M., & Renz, M. E. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1442-1447.1987 · Cited by 13
Estrada, A., Laarveld, B., Li, B., & Redmond, M. J. (1995) · Immunological Investigations · doi:10.3109/08820139509060709 · Cited by 13
van der Werf, S., Briand, J., Plaue, S., BURCKARD, J., Girard, M. P., & Regenmortel, M. H. V. V. (1994) · Research in Virology · doi:10.1016/s0923-2516(07)80040-9 · Cited by 13
Reigel, F., Burkhardt, F., & Schilt, U. (1985) · Journal of Hygiene · doi:10.1017/s0022172400062896 · Cited by 12
Molecular biology in arteriosclerosis research.
Williams, D. L. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.3.213 · Cited by 14
Kleine, A. H., Glatz, J. F. C., van Nieuwenhoven, F. A., Vallingal, M. I. J., Salden, M., Bosman, F. T., Boersma, W. J. A., Zegers, N. D., & Vusse, G. J. (1990) · Molecular and Cellular Biochemistry · doi:10.1007/bf00231366 · Cited by 11
“Based on the published amino acid sequence of human H-FABPc [12], putative antigenic sequences were predicted using algorithms for: hydrophilicity [13, 14], a-helix and [3-turns [15, 16], surface probability [ 17 , 18], and flexibility [19], culminating in an antigenic index according to Jameson & Wolf [10] and Wolf e…”
MethodWhat Biotechnology Has to Offer Vaccine Development
Fields, B. N., & Chanock, R. M. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_3.s519 · Cited by 11
“sharp serotype-specific increases in titers of neutralizing antibody [16].”
BackgroundVaccination against poliomyelitis: present possibilities and future prospects.
Melnick, J. L. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.3.304 · Cited by 11
Neutralization of small RNA viruses by antibodies and antiviral agents 1
Rossmann, M. G. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.12.2676677 · Cited by 11
“Some antibodies require bivalent attachment that cross-links pentamers in order to neutralize the virus ( 15-17 ).”
BackgroundIJAZ, M. (1995) · Vaccine · doi:10.1016/0264-410x(95)98252-6 · Cited by 11
Solid phase synthesis of two cholera toxin B subunit antigens
Delmas, A. F., Gruaz‐Guyon, A., Halimi, H., Raulais, D., & Rivaille, P. (1985) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1985.tb02195.x · Cited by 11
Toward New Viral Vaccines for Man
Norrby, E. (1987) · Advances in virus research · doi:10.1016/s0065-3527(08)60473-x · Cited by 11
Development and application of synthetic peptides as vaccines
Schmidt, M. A. (1989) · Biotechnology Advances · doi:10.1016/0734-9750(89)90358-3 · Cited by 10
Coulepis, A. G., Anderson, B. N., & Gust, I. D. (1987) · Advances in virus research · doi:10.1016/s0065-3527(08)60476-5 · Cited by 10
Immune Responses to Synthetic Peptide Vaccines of Veterinary Importance
Frenchick, P. J., Sabara, M. I. J., Ijaz, M. K., & Babiuk, L. A. (1988) · Springer eBooks · doi:10.1007/978-1-4757-9268-3_12 · Cited by 10
Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant
Gorziglia, M. I., & Kapikian, A. Z. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4407-4412.1992 · Cited by 10
“It is of interest that administration of synthetic peptides from the VP1 protein of poliovirus type 1 following infection with this type were shown to boost the neutralizing antibody response to this virus (4).”
BackgroundWang, Y., Gao, M., Li, X., Zhu, W., Zhao, M., Li, J., Liu, X., Cao, L., Li, S., Zhang, S., et al. (2023) · mBio · doi:10.1128/mbio.02666-22 · Cited by 9
“parvum surface antigens, C57BL/6 mice were vaccinated using a strategy of priming with attenuated oocysts and boosting with synthetic peptides (36, 37).”
MethodCharacterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides
Smyth, M., Trudgett, A., Hoey, E. M., Martin, S. J., & Brown, F. (1992) · Archives of Virology · doi:10.1007/bf01309681 · Cited by 9
“In some cases, peptides which elicit a neutralizing antibody response correspond to internal regions of the virus capsid [6, 9] and some sites revealed by anti-peptide antibodies have not been observed in monoclonal antibody mapping, notably that on VP 1 of poliovirus [16].”
BackgroundBayer, H., & Hunsmann, G. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-2-515 · Cited by 9
Immunoreactivity of human and rabbit antisera to hepatitis A virus
Gauss‐Müller, V., & Deinhardt, F. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890240212 · Cited by 9
Peptides as Immunogens: Prospects for Synthetic Vaccines
Arnon, R. (1986) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71440-5_1 · Cited by 9
Synthetic vaccines: Present and future
Arnon, R., & Sela, M. (1985) · Annales de l Institut Pasteur Immunologie · doi:10.1016/s0769-2625(85)80112-4 · Cited by 9
Wiegers, K.-J., & Dernick, R. (1987) · Virology · doi:10.1016/0042-6822(87)90337-0 · Cited by 9
Bayer, H., Gruber, W., Schneider, J., & Hunsmann, G. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02069.x · Cited by 9
Phenotypic characterization of antigenic hybrids of poliovirus
Murdin, A. D., Kameda, A., Murray, M. G., & Wimmer, E. (1991) · Microbial Pathogenesis · doi:10.1016/0882-4010(91)90064-h · Cited by 8
Self-citationFimbriae of Escherichia coli as carriers of heterologous antigenic sequences
Klemm, P., & Hedegaard, L. (1990) · Research in Microbiology · doi:10.1016/0923-2508(90)90143-e · Cited by 8
Reactivity of Anti-peptide and Anti-poliovirus Type 3 Monoclonal Antibodies with Synthetic Peptides
Ferguson, M. A. J., Reed, S. E., & Minor, P. D. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-11-2527 · Cited by 8
Applying the Concept of Peptide Uniqueness to Anti-Polio Vaccination
Kanduc, D., Fasano, C., Capone, G., Delfino, A. P., Calabrò, M., & Polimeno, L. (2015) · Journal of Immunology Research · doi:10.1155/2015/541282 · Cited by 7
“, DNTVRET, RSRSES, RSRSESSIESF, and STTNKDK) from PV VP1 prime the immune system of rabbits for a long-lasting, virus-neutralizing IgG Ab response following a single inoculation of intact virus [16].”
BackgroundHorie, H., Sato, M., Doi, Y., & Hashizume, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00159-x · Cited by 8
Isolation and Characterization of Monoclonal Antibody-resistant Mutants of Newcastle Disease Virus
Samson, A. C. R., Russell, P. H., & Hallam, S. E. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-2-357 · Cited by 7
Subunit, Recombinant and Synthetic Hepatitis B Vaccines
Zuckerman, A. J. (1985) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528509092225 · Cited by 6
Poliovirus: Three-dimensional Structure of a Viral Antigen
Hogle, J. M., & Filman, D. J. (1989) · Advances in veterinary science and comparative medicine · doi:10.1016/b978-0-12-039233-9.50006-8 · Cited by 6
Antigenicity of amino-acid sequences from Clostridium difficile toxin B
Torres, J. F., & Monath, T. P. C. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-44-6-464 · Cited by 6
Spira, G., Pollock, R. R., Bargellesi, A., & Scharff, M. D. (1985) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013647 · Cited by 6
Chenciner, N., Randrianarison-Huetz, V., Delpeyroux, F., Hanania, N., Pedroza-Martins, L., Stratford-Perricaudet, L. D., Perricaudet, M., & Wain–Hobson, S. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.801 · Cited by 6
Melnick, J. L. (1991) · Springer eBooks · doi:10.1007/978-1-4615-8138-3_9 · Cited by 6
Emini, E. A., Schleif, W. A., Jameson, B. A., & Wimmer, E. (1985) · Journal of Virological Methods · doi:10.1016/0166-0934(85)90102-8 · Cited by 5
Self-citationExpression of a poliovirus type 1 neutralization epitope on a diphtheria toxin fusion protein
Phalipon, A., Crainic, R., & Kaczorek, M. (1989) · Vaccine · doi:10.1016/0264-410x(89)90052-2 · Cited by 5
Chemical Synthesis of Poliovirus Peptides and Neutralizing Antibody Responses
Murray, M. G., & Wimmer, E. (1988) · Springer eBooks · doi:10.1007/978-1-4757-9268-3_11 · Cited by 5
Self-citationFatty acid-binding protein as diagnostic marker of acute myocardial infarction in man
Kleine, A. H. (1993) · Research Publications (Maastricht University) · doi:10.26481/dis.19930618ak · Cited by 5
Cold Spring Harbor meeting: Building new vaccines
Williams, N. (1983) · Nature · doi:10.1038/306427a0 · Cited by 5
Synthetische Peptide und ihre Anwendungsmöglichkeiten
Moser, R., Klauser, S., Leist, T. P., Langen, H., Epprecht, T., & Gutte, B. (1985) · Angewandte Chemie · doi:10.1002/ange.19850970905 · Cited by 6
Thorpe, R. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-404940-6.50010-4 · Cited by 5
Synthetic Peptide Vaccines: Success at Last
Meloen, R. H., Casal, J. I., Dalsgaard, K., & Langeveld, J. (1995) · Springer eBooks · doi:10.1007/978-1-4613-0357-2_13 · Cited by 4
Polio vaccine: From empiricism and efficacyto scientific knowledge
Horaud, F., Crainic, R., & Blondel, B. (1985) · Annales de l Institut Pasteur Virologie · doi:10.1016/s0769-2617(85)80144-1 · Cited by 4
Intrinsic immunogenicity of an internal VP1 T-B epitope pair of type 1 poliovirus
Lewis, G. K., & Chu-Pei, F. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90221-i · Cited by 4
Recombinant DNA Approaches to Feline Leukemia Virus Immunization
Luciw, P. A., Parkes, D., Nest, G. V., DINA, D., Hendrix, K., & Gardner, M. B. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5110-8_18 · Cited by 4
Liu, L., Xu, B., Chen, L., Liu, J., Liu, W. Y., Xue, F., Feng, S., Jiang, E., Han, M., Shao, W., et al. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101245 · Cited by 3
“14,15 It is currently acknowledged that the P33 and P90 peptides are located at the binding sites of Nabs, such as A20, and the “ plateau ” -like region of the AAV2 virus.”
Biologie moléculaire du poliovirus
Blondel, B., Couderc, T., Pavio, N., & Colbère-Garapin, F. (1995) · Annales de l Institut Pasteur / Actualités · doi:10.1016/0924-4204(96)83612-2 · Cited by 5
The Antigenic Structure of the Rabies Virus Glycoprotein
Dietzschold, B., Wunner, W. H., Macfarlan, R. I., Wiktor, T. J., Kiel, M., Houghten, R. A., Lerner, R. A., Sutcliffe, J. G., & Koprowski, H. (1985) · Springer eBooks · doi:10.1007/978-3-642-70060-6_1 · Cited by 3
Vaccines and Principles of Immunization
Pearson, R. C., Dhein, C. R., & Gorham, J. R. (1986) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(86)50138-8 · Cited by 3
Studies on the molecular aspects of antigenic structure and virulence of poliovirus
Minor, P. D., Schild, G. C., Cann, A. J., Dunn, G., Evans, D. M. A., Ferguson, M. A. J., Stanway, G., Westrop, G. D., & Almond, J. W. (1986) · Annales de l Institut Pasteur Virologie · doi:10.1016/s0769-2617(86)80198-8 · Cited by 3
Vaccination strategies, the Power of the Unmatched Double Hits
Al‐Qaisi, T. S., & Abumsimir, B. (2023) · Future Science OA · doi:10.2144/fsoa-2023-0090 · Cited by 3
Next Steps in the Evolution of Vaccinology
SALK, J. E., & Zanetti, M. (1989) · Progress in vaccinology · doi:10.1007/978-1-4612-3508-8_43 · Cited by 3
The development of subunit and synthetic vaccines using recombinant DNA technology
Lo, R. Y. C. (1987) · Biotechnology Advances · doi:10.1016/0734-9750(87)90320-x · Cited by 2
[Measurement of equivalent veiling luminance in ophthalmology. I. Introduction].
Verriest, G., Laethem, J. V., Benozzi, J., & Uvijls, A. (1982) · PubMed · Cited by 2
Mesyanzhinov, V. V., Peletskaya, E. N., Zhdanov, V. M., Efimov, A. V., Finkelstein, A. V., & Ivanovsky, D. I. (1987) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1987.10506404 · Cited by 2
Metadata
- Authors
- Emini, E. A., Jameson, B. A., & Wimmer, E.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- State University of New York (US)
- ORCID
- Wimmer, Eckard
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5928
- Pages
- 699-703
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989110977
- Cited by
- 237
- References
- 33
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 28.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- poliovirus type 1, synthetic peptides, peptide immunization, immune priming, neutralizing antibodies, IgG antibody response, rabbit immunization
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antibodies, Viral, Antigen-Antibody Complex, Antigens, Viral, Enzyme-Linked Immunosorbent Assay, Peptides, Rabbits, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.